Week of August 2 - 8, 2015
OncoLink eNews July/August 2015
Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email.
Panobinostat (Farydak ®) is an oral chemotherapy given in combination with other medications for the treatment of several types of cancers.
Palbociclib (Ibrance®) is an oral therapy for postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
Lenvatininb (Lenvima) is a VEGF tyrosine kinase inhibitor used in the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
OncoLink's blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Don’t Assume You Understand
by Bob Riter
Homeopathy: What You Should Know
by The 4Wholeness Team
OncoLink Survey: Do you have a Personal Emergency Kit?
by OncoLink Editorial Team
Retired Nurses and Their Memories of Cancer
by Bob Riter
National Cancer Survivors Day 2015 Wrap Up
by Carolyn Vachani, MSN, RN, AOCN
See all recent posts [RSS]
I Wish You Knew
How an oncology social worker can improve your cancer experience
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!